|
|
Volumn 30, Issue 5, 1998, Pages 1742-1743
|
|
Renal recipients of haploidentical living donors treated with neoral or conventional cyclosporine: A comparative follow-up of 3 years
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOSPORIN A;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED STUDY;
FEMALE;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY DONOR;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LIVING DONOR;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ADMINISTRATION, ORAL;
AZATHIOPRINE;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
GRAFT SURVIVAL;
HAPLOTYPES;
HISTOCOMPATIBILITY TESTING;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
LIVING DONORS;
LONGITUDINAL STUDIES;
MALE;
NUCLEAR FAMILY;
PREDNISONE;
PROSPECTIVE STUDIES;
REOPERATION;
TIME FACTORS;
|
|
EID: 0031710164
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)00411-4 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (5)
|
